KalVista Investigative Site

Wheaton, Maryland 20902

1 studies enrolling now · 2 studies all time

What they study most

Hereditary Angioedema

Studies at this site

• Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II — Completed
• Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat — Available (expanded access)